Nephrotic Syndrome Pipeline Report 2016 - Therapeutics Review of Asahi Kasei Pharma, Bristol-Myers Squibb, Orbis Biosciences & Retrophin - Research and Markets

DUBLIN--()--Research and Markets has announced the addition of the "Nephrotic Syndrome - Pipeline Review, H1 2016" report to their offering.

This report provides comprehensive information on the therapeutic development for Nephrotic Syndrome, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Nephrotic Syndrome and special features on late-stage and discontinued projects.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Key Topics Covered:

  1. Introduction
  2. Nephrotic Syndrome Overview
  3. Therapeutics Development
  4. Pipeline Products for Nephrotic Syndrome - Overview
  5. Pipeline Products for Nephrotic Syndrome - Comparative Analysis
  6. Nephrotic Syndrome - Therapeutics under Development by Companies
  7. Nephrotic Syndrome - Therapeutics under Investigation by Universities/Institutes
  8. Nephrotic Syndrome Products Glance
  9. Late Stage Products
  10. Clinical Stage Products
  11. Early Stage Products
  12. Nephrotic Syndrome - Products under Development by Companies
  13. Nephrotic Syndrome - Products under Investigation by Universities/Institutes
  14. Nephrotic Syndrome - Companies Involved in Therapeutics Development
  • Asahi Kasei Pharma Corp.
  • Bristol-Myers Squibb Company
  • Orbis Biosciences, Inc.
  • Retrophin Inc.

For more information visit http://www.researchandmarkets.com/research/kqflnw/nephrotic

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Sector: Liver and Kidney Disorders Drugs

Contacts

Research and Markets
Laura Wood, Senior Manager
press@researchandmarkets.com

For E.S.T Office Hours Call 1-917-300-0470
For U.S./CAN Toll Free Call 1-800-526-8630
For GMT Office Hours Call +353-1-416-8900

U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716

Sector: Liver and Kidney Disorders Drugs